Clinical Trials Browser

Phase 2/3 × INDUSTRY × Papillomavirus Infections × Clear all

NCT01824992 2013-04-05

Recombinant Human Interferon a-2b Gel for HPV Gynecological Infections

Phase 2/3 Completed

Papillomavirus Infections